Back
Speaker illustration

Doctor Luigi Spadafora

Sapienza University of Rome, Latina (Italy)

Member of:

European Society of Cardiology
European Association of Preventive Cardiology
European Association of Percutaneous Cardiovascular Interventions
Heart Failure Association of the ESC

Luigi Spadafora is a cardiologist at Ospedale Santa Maria Goretti in Latina, Italy, and a PhD student in Experimental Medicine at Sapienza University of Rome. He serves as Associate Editor for the Journal of Cardiovascular Pharmacology and is a member of the Board of the Italian Society of Cardiology, Lazio regional section. He holds a Master’s degree in Epidemiology and Biostatistics from the Catholic University of the Sacred Heart in Rome and is a Fellow of the Italian Society of Cardiology. He is fully certified in heart failure by the Heart Failure Association. His main fields of interest include coronary artery disease, interventional cardiology, cardio-oncology, and heart failure.

Presentations Articles

Benefits of physiology-guided complete revascularization of non-culprit lesions in elderly patients with myocardial infarction across the spectrum of GRACE score: insights from the FIRE trial.

Event: ESC Congress 2025

Topic: Intracoronary Flow and Pressure Measurements

Session: Coronary physiology and microcirculatory assessment

Access
Like
Thumbnail

SGLT2 inhibitors improve cardiovascular clinical outcomes in patients undergoing anthracycline chemotherapy: a systematic review and meta-analysis of 13,333 patients.

Event: ESC Congress 2025

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: SGLT2 inhibitors in heart failure: prevention and treatment

Access
Like
Thumbnail

One-year clinical outcomes of NSTEMI patients according to left ventricular ejection fraction: data from a large multicenter registry.

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Insights into incident heart failure

Access
Like
Thumbnail

Features and predictors of 1-year outcomes in cancer patients discharged after acute coronary syndrome: insights from a multicenter registry.

Event: ESC Cardio-Oncology 2025

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Session: Decoding cardiac biomarkers and coronary interventions in patients with cancer

Access
Like
Thumbnail

Higher systolic pulmonary artery pressure as a predictor of anthracycline-induced cardiac dysfunction in patients with hematologic malignancies.

Event: ESC Cardio-Oncology 2025

Topic: Stratification, Prevention and Monitoring

Session: Poster session (2)

Access
Like
Thumbnail

Impact of different types of hematologic disorders on anthracycline-induced cardiotoxicity: a retrospective analysis.

Event: ESC Cardio-Oncology 2025

Topic: Stratification, Prevention and Monitoring

Session: Poster session (1)

Access
Like
Thumbnail

Clinical predictors of one-year mortality in STEMI patients across the spectrum of LVEF: insights from a large multicenter registry.

Event: Heart Failure 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular heart disease, LV and RV function and imaging

Access
Like
Thumbnail

Regional disparities in STEMI management and outcomes in italy: an analysis of time-dependent reperfusion networks and in-hospital logistics

Event: ESC Preventive Cardiology 2025

Topic: Prevention

Session: Poster session (2)

Access
Like
Thumbnail

Hemoglobin/creatinine ratio as long- term prognostic marker in acute coronary syndromes: a praise registry study.

Event: ESC Congress 2024

Topic: Biomarkers

Session: Risk factors, risk scores, and outcomes after acute coronary syndromes

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources